Transitory tyrosinaemia of newborn (Q45883): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Níveis elevados de tirosina no sangue, clinicamente assintomático, causado por maturação fetal tardia da 4-hidroxifenilpiruvato dioxigenase, geralmente detectado no exame de rastreamento neonatal. Mais comumente observada em bebês prematuros recebendo fórmulas lácteas com alto teor de proteína. Geralmente considerado benigno, ocorre remissão por volta das 4-6 semanas de vida. | |||
| description / en | description / en | ||
Clinically asymptomatic elevated blood tyrosine level caused by late fetal maturation of 4-hydroxyphenylpyruvate dioxygenase, usually detected on newborn bloodspot screening. Most commonly seen in premature infants receiving milk formulae with high protein content. Generally considered benign and resolves by 4-6 weeks of age. | |||
Revision as of 14:08, 13 August 2026
Clinically asymptomatic elevated blood tyrosine level caused by late fetal maturation of 4-hydroxyphenylpyruvate dioxygenase, usually detected on newborn bloodspot screening. Most commonly seen in premature infants receiving milk formulae with high protein content. Generally considered benign and resolves by 4-6 weeks of age.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | KB63.4 |
||
| English | Transitory tyrosinaemia of newborn |
Clinically asymptomatic elevated blood tyrosine level caused by late fetal maturation of 4-hydroxyphenylpyruvate dioxygenase, usually detected on newborn bloodspot screening. Most commonly seen in premature infants receiving milk formulae with high protein content. Generally considered benign and resolves by 4-6 weeks of age. |
